The data illustrates the share of individuals receiving hormone therapy for cancer in Scotland from 2009 to 2016. Throughout the seven year period, the share of individuals receiving hormone therapy as part of their treatment remained relatively the same. In 2016, 15.5% of individuals diagnosed with cancer in Scotland had hormone therapy as part of their treatment. This was an increase on the previous year's share which amounted to 14.9%.
2009 | 85.7 | 12 | 2.3 |
2010 | 85.2 | 13 | 1.9 |
2011 | 84.1 | 15.2 | 0.7 |
2012 | 84.5 | 15.3 | 0.2 |
2013 | 84.3 | 15.5 | 0.2 |
2014 | 84.5 | 15.3 | 0.2 |
2015 | 84.9 | 14.9 | 0.3 |
2016 | 84.4 | 15.5 | 0.1 |